Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Itakura

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Pancreas|September 21, 2017
Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic JuiceShinichi Takano, Mitsuharu Fukasawa, Makoto Kadokura, et al.
Journal of Gastroenterology|December 17, 2013
Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patientsNobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, et al.
Diagnostics (Basel, Switzerland)|April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C PatientsTsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Oncology|July 8, 2011
Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablationKaoru Tsuchiya, Mina Komuta, Yutaka Yasui, et al.
Plos One|September 15, 2015
Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based TherapyJun Itakura, Masayuki Kurosaki, Mayu Higuchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopyHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Nakanishi, et al.
Scientific Reports|March 23, 2017
Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular CarcinomaNobuharu Tamaki, Atsushi Kuno, Atsushi Matsuda, et al.
Plos One|September 10, 2015
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New RegimensNobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Journal of Hepatology|March 11, 2008
The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapyMasayuki Kurosaki, Kotaro Matsunaga, Itsuko Hirayama, et al.
Annals of Surgical Oncology|June 8, 2021
Exposure to Blood Components and Inflammation Contribute to Pancreatic Cancer ProgressionRyo Saito, Hiromichi Kawaida, Naohiro Hosomura, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Pancreas|September 21, 2017
Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic JuiceShinichi Takano, Mitsuharu Fukasawa, Makoto Kadokura, et al.
Journal of Gastroenterology|December 17, 2013
Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patientsNobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, et al.
Diagnostics (Basel, Switzerland)|April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C PatientsTsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Oncology|July 8, 2011
Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablationKaoru Tsuchiya, Mina Komuta, Yutaka Yasui, et al.
Plos One|September 15, 2015
Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based TherapyJun Itakura, Masayuki Kurosaki, Mayu Higuchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopyHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Nakanishi, et al.
Scientific Reports|March 23, 2017
Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular CarcinomaNobuharu Tamaki, Atsushi Kuno, Atsushi Matsuda, et al.
Plos One|September 10, 2015
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New RegimensNobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Journal of Hepatology|March 11, 2008
The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapyMasayuki Kurosaki, Kotaro Matsunaga, Itsuko Hirayama, et al.
Annals of Surgical Oncology|June 8, 2021
Exposure to Blood Components and Inflammation Contribute to Pancreatic Cancer ProgressionRyo Saito, Hiromichi Kawaida, Naohiro Hosomura, et al.
Pageof 13